Xeris Biopharma Holdings, Inc. (XERS) Earnings Per Share (EPS)
Xeris Biopharma Holdings, Inc. (XERS) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$1.55 |
| 2022-12-31 | -$0.70 |
| 2023-03-31 | -$0.12 |
| 2023-06-30 | N/A |
| 2023-12-31 | -$0.45 |
| 2024-12-31 | -$0.37 |
| 2025-12-31 | N/A |
How XERS compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| INNV | InnovAge Holding Corp. | -$0.22 |
| TRVI | Trevi Therapeutics Inc. | -$0.32 |
| ACRS | Aclaris Therapeutics Inc. | -$0.53 |
| CRVS | Corvus Pharmaceuticals Inc. | -$0.53 |
| ALDX | Aldeyra Therapeutics Inc. | -$0.56 |
These are five companies in the same sector as XERS with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("XERS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | XERS | $8.43 | -0.12% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 |